Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors, Expert Review of Hematology, vol.97, issue.13, pp.43-56, 2015. ,
DOI : 10.1073/pnas.97.13.7521
The core-binding factor leukemias: lessons learned from murine models, Current Opinion in Genetics & Development, vol.13, issue.1, pp.48-54, 2003. ,
DOI : 10.1016/S0959-437X(02)00018-7
AML1-ETO translocations in childhood acute myeloid leukemia, In utero origin of t Blood, vol.21, issue.99, pp.3801-3806, 2002. ,
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia, Blood, vol.87, pp.4789-96, 1996. ,
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia, Blood, vol.121, issue.12 ,
DOI : 10.1182/blood-2012-10-462879
, Blood, vol.121, pp.2213-2236, 2013.
Comprehensive mutational profiling of core binding factor acute myeloid leukemia, Blood, vol.127, issue.20, pp.2451-2460, 2016. ,
DOI : 10.1182/blood-2015-12-688705
The genomic landscape of core-binding factor acute myeloid leukemias, Nature Genetics, vol.511, issue.12, pp.1551-1557, 2016. ,
DOI : 10.1016/j.celrep.2012.12.008
URL : http://europepmc.org/articles/pmc5508996?pdf=render
Individual Patient Data???Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup, Journal of Clinical Oncology, vol.22, issue.18, pp.3741-50, 2004. ,
DOI : 10.1200/JCO.2004.03.012
Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study, Journal of Clinical Oncology, vol.23, issue.24, pp.5705-5722, 2005. ,
DOI : 10.1200/JCO.2005.15.610
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations, British Journal of Haematology, vol.88, issue.2, pp.165-73, 2006. ,
DOI : 10.1038/nrc840
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2006.06276.x/pdf
GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples, Bioinformatics, vol.102, issue.6, pp.2981-2983, 2012. ,
DOI : 10.1038/sj.bjc.6605589
URL : https://academic.oup.com/bioinformatics/article-pdf/28/22/2981/662324/bts547.pdf
Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia, Genes, Chromosomes and Cancer, vol.98, issue.3, pp.279-91, 2005. ,
DOI : 10.3109/10428199809092683
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival, Blood, vol.111, issue.8, pp.4338-4385, 2008. ,
DOI : 10.1182/blood-2007-07-103291
Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia, Cancer Genetics and Cytogenetics, vol.188, issue.2 ,
DOI : 10.1016/j.cancergencyto.2008.10.004
, Cancer Genet Cytogenet, vol.188, pp.83-90, 2009.
EZH2 Mutations Are Related to Low Blast Percentage in Bone Marrow and -7/del(7q) in De Novo Acute Myeloid Leukemia, PLoS ONE, vol.18, issue.4, p.61341, 2013. ,
DOI : 10.1371/journal.pone.0061341.s002
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia, Cancer Cell, vol.25, issue.5, pp.652-65, 2014. ,
DOI : 10.1016/j.ccr.2014.03.016
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations, Blood, vol.119, issue.10, pp.67-75, 2012. ,
DOI : 10.1182/blood-2011-09-380444
Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression, Molecular Cancer, vol.288, issue.1, pp.90-12943, 2015. ,
DOI : 10.1006/bbrc.2001.5798
Not4 enhances JAK/STAT pathway-dependent gene expression in Drosophila and in human cells, The FASEB Journal, vol.118, issue.3, pp.1239-50, 2012. ,
DOI : 10.1042/BJ20090500
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation, Nature Communications, vol.31, p.11733, 2016. ,
DOI : 10.1093/bioinformatics/btv362
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature, Blood, vol.127, issue.20, pp.2498-501, 2016. ,
DOI : 10.1182/blood-2016-03-703868
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia, Proceedings of the National Academy of Sciences, vol.456, issue.7218, pp.12944-12949, 2009. ,
DOI : 10.1038/nature07485
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia, Oncotarget. Leukemia, vol.5, issue.31, pp.916-948, 2013. ,
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome, Leukemia, vol.102, issue.7, pp.1449-58, 2014. ,
DOI : 10.1182/blood-2002-11-3527
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG), Blood, vol.121, issue.1, pp.170-177, 2013. ,
DOI : 10.1182/blood-2012-05-431486
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations, Blood, vol.124, issue.9, pp.1445-1454, 2014. ,
DOI : 10.1182/blood-2014-04-571018
URL : http://www.bloodjournal.org/content/bloodjournal/124/9/1445.full.pdf
Cancer genetics and genomics of human FOX family genes, Cancer Letters, vol.328, issue.2 ,
DOI : 10.1016/j.canlet.2012.09.017
, Cancer Lett, vol.328, pp.198-206, 2013.
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression, Blood, vol.118, issue.1, pp.167-76, 2011. ,
DOI : 10.1182/blood-2011-01-331678
Comment on ???Integrative genomic profiling of human prostate cancer???, Leukemia, vol.24, issue.11, pp.1970-1972, 2010. ,
DOI : 10.1261/rna.1532109
Clinical significance of genetic aberrations in secondary acute myeloid leukemia, American Journal of Hematology, vol.112, issue.11, pp.1010-1016, 2012. ,
DOI : 10.1046/j.1365-2141.2001.02511.x
,
, Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function, Blood, vol.112, pp.4699-711, 2008.
Somatic human ZBTB7A zinc finger mutations promote cancer progression, Oncogene, vol.464, issue.23, pp.3071-3079, 2016. ,
DOI : 10.1038/nprot.2006.27
Is CCDC26 a Novel Cancer-Associated Long- Chain Non-Coding RNA? Oncogene and Cancer -From Bench to Clinic, pp.415-449, 2013. ,
Genome-wide association study identifies five susceptibility loci for glioma, Nature Genetics, vol.16, issue.8, pp.899-904, 2009. ,
DOI : 10.1038/nmeth.1282
Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer, Biomedicine & Pharmacotherapy, vol.83, pp.712-719, 2016. ,
DOI : 10.1016/j.biopha.2016.06.059
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM, Oncogene, vol.25, issue.26, pp.3735-3779, 2006. ,
DOI : 10.1074/jbc.274.17.11549
URL : https://hal.archives-ouvertes.fr/hal-00188233
The role of the CCDC26 long noncoding RNA as a tumor suppressor, RNA Dis, 2015. ,
New Lesions Detected by Single Nucleotide Polymorphism Array???Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.27, issue.31, pp.5219-5245, 2009. ,
DOI : 10.1200/JCO.2009.21.9840
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies, Blood, vol.115, issue.14, pp.2731-2740, 2009. ,
DOI : 10.1182/blood-2009-10-201848
SNP array analysis in hematologic malignancies: avoiding false discoveries, Blood, vol.115, issue.21, pp.4157-61, 2009. ,
DOI : 10.1182/blood-2009-11-203182